InsidersTradesSigma
Track the Polaryx Therapeutics, Inc. share price and the full insider trade history of the company, a listed equity based in United States. Shares are listed on US US, under the supervision of SEC (Form 4). The latest transaction was filed on 20 February 2026 (Acquisition). Among the most active insiders: Landis G. Michael. Every trade is free.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration
Polaryx Therapeutics, Inc. is a biopharmaceutical company focused on developing innovative treatments for rare diseases. It is listed on NASDAQ under the ticker PLYX.